News Conference News ESC 2022 P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER Todd Neale August 29, 2022
News Conference News ESC 2021 Prasugrel Tops Ticagrelor in ACS Across the eGFR Spectrum: ISAR-REACT 5 Todd Neale August 24, 2021
News Conference News ESC 2019 Another Step Forward for Genotype-Guided Prescribing After PCI: POPular Genetics Yael L. Maxwell September 03, 2019
News Conference News ESC 2019 For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI Todd Neale September 03, 2019
News Conference News ESC 2019 Prasugrel Bests Ticagrelor in ACS Patients Heading to PCI: ISAR-REACT 5 Shelley Wood September 01, 2019
News Conference News ESC 2019 COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter Yael L. Maxwell September 01, 2019
News Conference News ESC 2019 ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More Shelley Wood August 22, 2019
News Conference News ESC 2018 My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More Shelley Wood September 14, 2018
News Conference News ESC 2018 Pretreatment With P2Y12 Inhibitors Questioned Anew in SCAAR Shelley Wood August 28, 2018
News Conference News ESC 2018 ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More Shelley Wood August 20, 2018